Headinvest LLC Maintains Position in Aetna Inc. (AET)
Headinvest LLC maintained its stake in Aetna Inc. (NYSE:AET) during the second quarter, Holdings Channel reports. The institutional investor owned 2,190 shares of the company’s stock at the end of the second quarter. Headinvest LLC’s holdings in Aetna were worth $267,000 as of its most recent filing with the SEC.
Other hedge funds have also recently bought and sold shares of the company. OLD National Bancorp IN increased its stake in Aetna by 10.5% in the first quarter. OLD National Bancorp IN now owns 4,080 shares of the company’s stock worth $458,000 after buying an additional 387 shares in the last quarter. Legacy Private Trust Co. increased its stake in Aetna by 11.9% in the first quarter. Legacy Private Trust Co. now owns 26,660 shares of the company’s stock worth $2,995,000 after buying an additional 2,840 shares in the last quarter. Nepsis Capital Management Inc. increased its stake in Aetna by 6.6% in the first quarter. Nepsis Capital Management Inc. now owns 49,752 shares of the company’s stock worth $5,590,000 after buying an additional 3,092 shares in the last quarter. Wilbanks Smith & Thomas Asset Management LLC increased its stake in Aetna by 1.6% in the first quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 20,805 shares of the company’s stock worth $2,337,000 after buying an additional 333 shares in the last quarter. Finally, Glenmede Trust Co. NA increased its stake in Aetna by 5.3% in the first quarter. Glenmede Trust Co. NA now owns 229,529 shares of the company’s stock worth $25,787,000 after buying an additional 11,648 shares in the last quarter. 91.95% of the stock is currently owned by institutional investors.
Shares of Aetna Inc. (NYSE:AET) traded up 0.21% on Thursday, reaching $116.93. The company’s stock had a trading volume of 1,506,802 shares. Aetna Inc. has a 52-week low of $92.42 and a 52-week high of $123.57. The company has a 50 day moving average price of $117.42 and a 200 day moving average price of $115.51. The company has a market cap of $41.02 billion, a P/E ratio of 17.14 and a beta of 0.62.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, August 2nd. The company reported $2.21 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.12 by $0.09. The company had revenue of $15.95 billion for the quarter, compared to the consensus estimate of $15.69 billion. Aetna had a return on equity of 16.44% and a net margin of 3.89%. The firm’s quarterly revenue was up 4.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.05 EPS. On average, analysts anticipate that Aetna Inc. will post $8.05 earnings per share for the current fiscal year.
AET has been the topic of a number of research reports. Wells Fargo & Co. reissued a “buy” rating on shares of Aetna in a research note on Thursday, June 2nd. Morgan Stanley reissued a “buy” rating on shares of Aetna in a research note on Tuesday, June 14th. Sanford C. Bernstein initiated coverage on Aetna in a research note on Thursday, June 16th. They issued an “outperform” rating and a $142.00 price objective on the stock. Leerink Swann reissued an “outperform” rating on shares of Aetna in a research note on Tuesday, June 21st. Finally, Wolfe Research began coverage on Aetna in a research report on Tuesday, June 28th. They set an “outperform” rating and a $154.00 target price on the stock. Eight investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $133.15.
In other news, Director Jeffrey E. Garten sold 7,100 shares of the stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total value of $827,221.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Shawn M. Guertin sold 45,328 shares of the stock in a transaction on Tuesday, August 23rd. The shares were sold at an average price of $120.21, for a total value of $5,448,878.88. Following the completion of the transaction, the insider now directly owns 44,883 shares in the company, valued at approximately $5,395,385.43. The disclosure for this sale can be found here. 0.90% of the stock is owned by insiders.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.